1-9 of 9
Ling Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1 -mutated AML

Onyee Chan, Najla Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad Hussaini, Jinming Song, Seongseok Yun, Chetasi Talati, Andrew Kuykendall, Eric Padron, Alison Walker, Gail Roboz, Pinkal Desai, David Sallman, Kendra Sweet, Rami Komrokji, Jeffrey Lancet
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1075–1083.
https://doi.org/10.1182/bloodadvances.2023011173
Published: 2024
Journal Articles

Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies

Clinical Trials & Observations
Edward J. Gorak, Michael Otterstatter, Tareq Al Baghdadi, Nancy Gillis, James M. Foran, Jane Jijun Liu, Rafael Bejar, Steven D. Gore, Steven H. Kroft, Alexandra Harrington, Wael Saber, Daniel Starczynowski, Dana E. Rollison, Ling Zhang, Lynn Moscinski, Steffanie Wilson, Jason Thompson, Christine Borchert, Seth Sherman, Donnie Hebert, Mary Ellen Walker, Eric Padron, Amy E. DeZern, Mikkael A. Sekeres
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6120–6129.
https://doi.org/10.1182/bloodadvances.2023010061
Published: 2023
Includes: Supplemental data
Journal Articles

Anti-CD19 CAR T-cell consolidation therapy combined with CD19 + feeding T cells and TKI for Ph + acute lymphoblastic leukemia

Clinical Trials & Observations
Li-Yun Chen, Wen-Jie Gong, Ming-Hao Li, Hai-Xia Zhou, Ming-Zhu Xu, Chong-Sheng Qian, Li-Qing Kang, Nan Xu, Zhou Yu, Man Qiao, Tong-Tong Zhang, Ling Zhang, Zheng-Long Tian, Ai-Ning Sun, Lei Yu, De-Pei Wu, Sheng-Li Xue
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4913–4925.
https://doi.org/10.1182/bloodadvances.2022009072
Published: 2023
Includes: Supplemental data
Journal Articles

Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions

Amy E. DeZern, Johannes B. Goll, R. Coleman Lindsley, Rafael Bejar, Steffanie H. Wilson, Donnie Hebert, Joachim Deeg, Ling Zhang, Steven Gore, Tareq Al Baghdadi, Jaroslaw Maciejewski, Jane Liu, Eric Padron, Rami Komrojki, Wael Saber, Gregory Abel, Steven H. Kroft, Alexandra Harrington, Tyler Grimes, Harrison Reed, Robert S. Fulton, Nancy L. DiFronzo, Nancy Gillis, Mikkael A. Sekeres, Matthew J. Walter
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3749–3759.
https://doi.org/10.1182/bloodadvances.2022008578
Published: 2023
Includes: Supplemental data
Journal Articles

Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant

Clinical Trials & Observations
Seongseok Yun, Onyee Chan, Daniel Kerr, Nicole D. Vincelette, Afshan Idrees, Qianxing Mo, Kendra Sweet, Jeffrey E. Lancet, Mohamed A. Kharfan-Dabaja, Ling Zhang, Lubomir Sokol
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3435–3442.
https://doi.org/10.1182/bloodadvances.2020001875
Published: 2020
Includes: Supplemental data
Journal Articles

First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG

Clinical Trials & Observations
Shu-Nan Qi, Yong Yang, Yu-Qin Song, Ying Wang, Xia He, Chen Hu, Li-Ling Zhang, Gang Wu, Bao-Lin Qu, Li-Ting Qian, Xiao-Rong Hou, Fu-Quan Zhang, Xue-Ying Qiao, Hua Wang, Gao-Feng Li, Hui-Qiang Huang, Yu-Jing Zhang, Yuan Zhu, Jian-Zhong Cao, Jun-Xin Wu, Tao Wu, Su-Yu Zhu, Mei Shi, Li-Ming Xu, Zhi-Yong Yuan, Hang Su, Jun Zhu, Ye-Xiong Li
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3141–3153.
https://doi.org/10.1182/bloodadvances.2020001852
Published: 2020
Includes: Supplemental data
Journal Articles

The pan-PIM inhibitor INCB053914 displays potent synergy in combination with ruxolitinib in models of MPN

Lucia Mazzacurati, Robert J. Collins, Garima Pandey, Que T. Lambert-Showers, Narmin E. Amin, Ling Zhang, Matthew C. Stubbs, Pearlie K. Epling-Burnette, Holly K. Koblish, Gary W. Reuther
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3503–3514.
https://doi.org/10.1182/bloodadvances.2019000260
Published: 2019
Includes: Supplemental data
Journal Articles

Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group

Clinical Trials & Observations
Tao Wu, Yong Yang, Su-Yu Zhu, Mei Shi, Hang Su, Ying Wang, Xia He, Li-Ming Xu, Zhi-Yong Yuan, Li-Ling Zhang, Gang Wu, Bao-Lin Qu, Li-Ting Qian, Xiao-Rong Hou, Fu-Quan Zhang, Yu-Jing Zhang, Yuan Zhu, Jian-Zhong Cao, Sheng-Min Lan, Jun-Xin Wu, Chen Hu, Shu-Nan Qi, Bo Chen, Ye-Xiong Li
Journal: Blood Advances
Blood Adv (2018) 2 (18): 2369–2377.
https://doi.org/10.1182/bloodadvances.2018021311
Published: 2018
Includes: Supplemental data
Journal Articles

Loss of mDia1 causes neutropenia via attenuated CD11b endocytosis and increased neutrophil adhesion to the endothelium

Yang Mei, Gong Feng, Nina Rahimi, Baobing Zhao, Jingxin Zhang, Lan Cao, Jing Yang, Juehua Gao, Yihua Chen, Ronen Sumagin, William A. Muller, Ling Zhang, Peng Ji
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1650–1656.
https://doi.org/10.1182/bloodadvances.2017007906
Published: 2017
Includes: Multimedia, Supplemental data